LONDON and WASHINGTON, D.C., December 1, 2025 — Arnold & Porter announced today that George Jenkins has joined the firm's Corporate & Finance practice as a partner, resident in London.
Kathleen Harris, head of Arnold & Porter's London office, said: "George brings exceptional experience in guiding complex life sciences transactions. His arrival comes at an essential time, as the U.K. and EU markets face rapid change driven by emerging technologies and evolving regulatory frameworks. George's insight will strengthen our London team and further enhance the firm's ability to deliver seamless cross-border solutions."
George has extensive experience advising on sophisticated life sciences agreements and transactions that are often cross-jurisdictional. He represents companies of all sizes across the biotech, life sciences, pharmaceutical, and digital health industries, guiding them through the structuring, negotiating, and drafting of their collaborations, joint ventures, IP licensing, and co-development arrangements, as well as agreements for the manufacture, distribution, and supply of goods. George also counsels companies on regulatory issues in the life sciences sector, including licensing and regulatory requirements, to help clients develop and bring their products to market in the EU.
In joining the firm, George said: "Arnold & Porter's reputation for excellence in the life sciences industry, combined with its London presence and global platform, offers an unparalleled opportunity to serve clients in this dynamic sector. I look forward to working with my colleagues in the U.K. and internationally to support clients in navigating their most pivotal transactions."
George holds an M.Sc. from The London School of Economics and Political Science and a B.A. from the University of Oxford.